Evaluating the Impact of Personalized Move Goals on Physical Activity

Sponsor
Welltory Inc. (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05123989
Collaborator
(none)
300
3
10.9

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the impact of personalized move goals in the Welltory mobile app on daily step count among adults from 30 to 65 years old. The study also aims to assess how personalized move goals impact workout quality and frequency.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Personalized move goals
  • Behavioral: Constant move goals
N/A

Detailed Description

The Welltory app sends users messages with move goals to help people move smarter. Adapted daily based on each user's historical data and overall wellbeing, Welltory's move goals gradually increase physical activity levels, motivating sedentary people to move more without demanding drastic lifestyle changes.

This randomized controlled study will assess if messages with personalized move goals in the Welltory mobile app help increase physical activity among adults.

Participants include individuals aged 30-65 who use iPhones, wear an Apple Watch, and lead sedentary lifestyles (their median daily step count does not exceed 6,000). Participants are selected among active Wellotry mobile app users who had previously not received any messages with move goals.

All participants are randomly assigned to 3 groups:
  • Participants in group 1 receive daily messages with personalized move goals in the Welltory mobile app. Personalized move goals are computed based on each participant's historical physical activity data and their daily wellbeing.

  • Participants in group 2 receive daily messages with a static move goal of 10,000 steps per day in the Welltory mobile app.

  • Participants in group 3 use the Welltory mobile app but don't receive any messages with move goals.

For all participants, steps and workouts are automatically registered by their Apple Watch wearable devices and the Welltory mobile app. Additionally, participants regularly measure their body weight and manually record it in the Welltory mobile app.

This study's duration spans a total of 24 weeks for each participant.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluating the Impact of Personalized Move Goals in a Mobile App on Physical Activity
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Aug 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Personalized move goals

Participants will be sent daily messages in the Welltory mobile app with personalized move goals that are based on each participant's historical physical activity data and their daily wellbeing

Behavioral: Personalized move goals
Personalized move goals delivered by the Welltory mobile app

Active Comparator: Constant move goals

Participants will be sent daily messages in the Welltory mobile app with a static move goal of 10,000 steps per day

Behavioral: Constant move goals
Static move goal delivered by the Welltory mobile app

No Intervention: No intervention

Participants will not be sent any messages with move goals in the Welltory mobile app

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline Average Steps per Day at 4 weeks [Baseline, 4 weeks]

  2. Change from Baseline Average Steps per Day at 8 weeks [Baseline, 8 weeks]

  3. Change from Baseline Average Steps per Day at 12 weeks [Baseline, 12 weeks]

  4. Change from Baseline Average Steps per Day at 24 weeks [Baseline, 24 weeks]

Secondary Outcome Measures

  1. Change from Baseline Body Weight at 12 weeks [Baseline, 12 weeks]

    Body weight in kilograms

  2. Change from Baseline Body Weight at 24 weeks [Baseline, 24 weeks]

    Body weight in kilograms

  3. Workouts at 4 weeks [4 weeks]

    Total number of workouts over 20 minutes during first 4 weeks of intervention

  4. Workouts at 8 weeks [8 weeks]

    Total number of workouts over 20 minutes during first 8 weeks of intervention

  5. Workouts at 12 weeks [12 weeks]

    Total number of workouts over 20 minutes during first 12 weeks of intervention

  6. Workouts at 24 weeks [24 weeks]

    Total number of workouts over 20 minutes during 24 weeks of intervention

  7. Active calories during workouts at 4 weeks [4 weeks]

    All active calories burned during workouts over 20 minutes

  8. Active calories during workouts at 8 weeks [8 weeks]

    All active calories burned during workouts over 20 minutes

  9. Active calories during workouts at 12 weeks [12 weeks]

    All active calories burned during workouts over 20 minutes

  10. Active calories during workouts at 24 weeks [24 weeks]

    All active calories burned during workouts over 20 minutes

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Using an iPhone smartphone

  • Using an Apple Watch

  • Willing to use the Welltory app every day for 6 months

  • Median daily step count is less than 6,000 in the month before the beginning of this study

Exclusion Criteria:
  • Already participating in another physical activity study

  • Known medical conditions or physical problems that require special attention in an exercise program

  • Pregnant/gave birth in the past 6 month

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Welltory Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Welltory Inc.
ClinicalTrials.gov Identifier:
NCT05123989
Other Study ID Numbers:
  • WELLTORY-CT001
First Posted:
Nov 17, 2021
Last Update Posted:
May 9, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 9, 2022